Alpha1-antitrypsin activity in subarachnoid hemorrhage

F. Tartara, P. Gaetani, F. Tancioni, A. Guagliano, C. Klersy, A. Forlino, F. Marzatico, R. R Y Baena

Research output: Contribution to journalArticlepeer-review


An altered equilibrium of protease/protease-inhibitor factors may be involved in the pathogenesis of aneurysm rupture: α1-antitrypsin (α1-AT) represents the most relevant inhibitor of elastase, a proteolytic enzyme enhancing catabolic processes of collagen metabolism. In the present study we test the hypothesis whether the activity of α1-AT is altered in SAH patients; 5 cases with unruptured intracranial aneurysm and 27 patients with diagnosis of aneurysm SAH were included in the study. Blood samples were obtained immediately at admission. As control samples we consider the 5 cases of unruptured aneurysm, 15 cases of unruptured aortic aneurysms and 10 patients with non-vascular CNS diseases. Measurement of α1-AT level was determined by immunoturbidimetric method. Serum levels of α1-AT are significantly lower in patients admitted within 72 hours after SAH, if compared to patients admitted in a delayed phase. The linear relationship between α1-AT and collagenase inhibitory percentage capacity (CIC) was shown to be different in the 4 subgroups considered, and so were the mean % CIC values in the between-groups comparison, except for unruptured aneurysm vs controls. The α1-AT CIC in patients with SAH is shown to be the lowest when compared to controls and unruptured aneurysms (p = 0.0001).

Original languageEnglish
Pages (from-to)15-20
Number of pages6
JournalLife Sciences
Issue number1
Publication statusPublished - May 31 1996


  • alpha1-antitrypsin
  • proteolytic damage
  • subarachnoid hemorrhage

ASJC Scopus subject areas

  • Pharmacology


Dive into the research topics of 'Alpha1-antitrypsin activity in subarachnoid hemorrhage'. Together they form a unique fingerprint.

Cite this